glp-1 results my honest weight loss journey GLP-1 Weight Loss Results |

Values presented as percentage of total Adverse events are presented for all participants who were randomised and took at least one dose of treatment, regardless of whether they discontinued * For the T2D trial, this was limited to supraventricular arrhythmias and cardiac conduction disorders ** For the obesity trial these are presented as hepatic disorder / biliary disorder separately NA : Not applicable In the obesity trial, serious adverse events (SAEs) occurred in 4% of participants with retatrutide use overall (06% across groups) vs

It is cold, fast, easy to portion, and easier to start than something heavier

Beam and Hunter Guevara 2023

Sebastiao I, Candeias E, Santos MS, de Oliveira CR, Moreira PI, Duarte AI

Some may stop and maintain with intensive behavioral and metabolic support

Takeaway: Ro provides GLP-1 prescriptions through telehealth visits with licensed clinicians, supports insurance navigation, and delivers medications to your door within a structured online program